Swiss Institute for Experimental Cancer Research

Swiss Institute for Experimental Cancer Research (ISREC), founded in 1964, is a prominent biomedical research institute located in Lausanne, Switzerland. It is dedicated to conducting cutting-edge research in the field of cancer biology and experimental cancer treatment. The institute is part of the School of Life Sciences of the École Polytechnique Fédérale de Lausanne (EPFL), one of the world's leading technical universities.

History

The Swiss Institute for Experimental Cancer Research was established with the primary goal of understanding the fundamental mechanisms of cancer and finding innovative therapies to combat the disease. Over the years, ISREC has grown significantly, contributing to major advances in cancer research. Its integration into the EPFL in 2008 marked a significant milestone, enhancing its research capabilities through access to state-of-the-art facilities and interdisciplinary collaboration.

Research Focus

ISREC's research activities are centered around understanding the molecular and cellular mechanisms that lead to cancer. The institute's work spans several key areas, including but not limited to:

• Genetics and genomics of cancer
• Tumor microenvironment
• Cancer immunotherapy
• Cell signaling in cancer
• Stem cells and cancer

Through its comprehensive research programs, ISREC aims to translate basic research findings into clinical applications that can benefit cancer patients.

Facilities and Resources

The institute boasts advanced research facilities that support its mission. These include state-of-the-art laboratories, high-throughput genomics platforms, and bioinformatics resources. ISREC also benefits from close collaborations with other research institutions and hospitals, facilitating the translation of its research into clinical practice.

Education and Training

ISREC is committed to educating the next generation of scientists and clinicians in the field of cancer research. It offers various educational programs and opportunities, including PhD and postdoctoral training, in collaboration with the EPFL and other academic institutions.

Notable Achievements

Over the years, ISREC has made significant contributions to the field of cancer research, including groundbreaking discoveries in cancer genetics, tumor biology, and the development of novel cancer therapies. Its researchers have received numerous awards and recognitions for their work.

Future Directions

The Swiss Institute for Experimental Cancer Research continues to push the boundaries of cancer research, with ongoing efforts to understand cancer's complexities and develop effective treatments. Its multidisciplinary approach and collaboration with researchers and clinicians worldwide are key to its future successes.

‎